Entero Therapeutics Inc (NASDAQ:ENTO) has a beta value of -99.96% and has seen 1.53 shares traded in the last trading session. The company, currently valued at $2.53M, closed the last trade at $0.48 per share which meant it lost -$35.52 on the day or 0.53% during that session. The ENTO stock price is -377.08% off its 52-week high price of $2.29 and 60.42% above the 52-week low of $0.19. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.73 million shares traded. The 3-month trading volume is 1.16 shares.

Entero Therapeutics Inc (NASDAQ:ENTO) trade information

Sporting 0.53% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ENTO stock price touched $0.48 or saw a rise of 15.12%. Year-to-date, Entero Therapeutics Inc shares have moved -74.47%, while the 5-day performance has seen it change -3.63%. Over the past 30 days, the shares of Entero Therapeutics Inc (NASDAQ:ENTO) have changed 23.20%. Short interest in the company has seen 1.24 million shares shorted with days to cover at 0.44.

Entero Therapeutics Inc (ENTO) estimates and forecasts

The company’s shares have lost -6.84% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 94.88% 82.03% over the past 5 years.

ENTO Dividends

Entero Therapeutics Inc is expected to release its next earnings report on 2025-Apr-01 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Entero Therapeutics Inc (NASDAQ:ENTO)’s Major holders

Insiders own 7.30% of the company shares, while shares held by institutions stand at 3.07% with a share float percentage of 3.31%. Investors are also buoyed by the number of investors in a company, with Entero Therapeutics Inc having a total of 9.0 institutions that hold shares in the company.